June 7, 2022
Life Sciences
  • Pfizer announced that it is investing $120 million to boost production of its Paxlovid COVID-19 treatment pills in the U.S. To date, Pfizer has shipped 12 million courses globally to 37 countries, including 5 million to the U.S. The investment will allow Pfizer to add 4 million more courses, in addition to creating more than 250 jobs at its Kalamazoo, Michigan plant. (Press release here; Article here)